FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160658355> ?p ?o ?g. }

• W3160658355 endingPage "218" @default.
• W3160658355 startingPage "206" @default.
• W3160658355 abstract "Treatment of glioblastoma (GBM) remains a challenging task, with limited treatment options, none offering a cure. Immune therapy has proven effective across different cancers with remarkable response rates. Tumor mutational burden (TMB) is a marker of response, but technical and methodological differences in TMB estimates have made a proper assessment and comparison challenging. Here, we analyzed a prospective collection of paired samples from 35 patients with newly diagnosed GBM, all of whom were wild-type (WT) for isocitrate dehydrogenase, before and after treatment with radiotherapy and temozolomide. Seven patients (20%) had O6-methylguanine-DNA methyltransferase-methylated tumors. Six patients (17%) had two relapse surgeries, and tissue from all three surgeries was collected. We found that accurate evaluation of TMB was confounded by high variability in the cancer cell fraction of relapse samples. To ameliorate this, we developed a model to adjust for tumor purity based on the relative density distribution of variant allele frequencies in each primary-relapse pair. Additionally, we examined the mutation spectra of shared and private mutations. After tumor purity adjustment, we found TMB comparison reliable in tumors with tumor purity between 15% and 40%, resulting in 27/35 patients (77.1%). TMB remained unchanged from 0.65 mutations per megabase (Mb) to 0.67/Mb before and after treatment, respectively. Examination of the mutation spectra revealed a dominance of C > T transitions at CpG sites in both shared and relapse-private mutations, consistent with cytosine deamination and the clock-like mutational signature 1. We present and apply a cellularity correction approach that enables more accurate assessment of TMB in paired tumor samples. We did not find a significant increase in TMB after correcting for cancer cell fraction. Our study raises significant concerns when determining TMB. Although a small sample size, corrected TMB can have a clinical significance when stratifying patients to experimental treatment, for example, immune checkpoint therapy." @default.
• W3160658355 created "2021-05-24" @default.
• W3160658355 creator A5000299131 @default.
• W3160658355 creator A5004172331 @default.
• W3160658355 creator A5004222553 @default.
• W3160658355 creator A5006614002 @default.
• W3160658355 creator A5017762827 @default.
• W3160658355 creator A5030356918 @default.
• W3160658355 creator A5044799176 @default.
• W3160658355 creator A5045491737 @default.
• W3160658355 creator A5064975863 @default.
• W3160658355 creator A5065750301 @default.
• W3160658355 creator A5077199450 @default.
• W3160658355 date "2021-06-25" @default.
• W3160658355 modified "2023-09-29" @default.
• W3160658355 title "Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study" @default.
• W3160658355 cites W2009720434 @default.
• W3160658355 cites W2022495797 @default.
• W3160658355 cites W2038914273 @default.
• W3160658355 cites W2049553585 @default.
• W3160658355 cites W2071191831 @default.
• W3160658355 cites W2090353215 @default.
• W3160658355 cites W2096287682 @default.
• W3160658355 cites W2104885590 @default.
• W3160658355 cites W2105100844 @default.
• W3160658355 cites W2107429737 @default.
• W3160658355 cites W2109816625 @default.
• W3160658355 cites W2117692326 @default.
• W3160658355 cites W2138601221 @default.
• W3160658355 cites W2152061559 @default.
• W3160658355 cites W2158681922 @default.
• W3160658355 cites W2165871546 @default.
• W3160658355 cites W2203070891 @default.
• W3160658355 cites W2291298003 @default.
• W3160658355 cites W2303158491 @default.
• W3160658355 cites W2366536035 @default.
• W3160658355 cites W2410468716 @default.
• W3160658355 cites W2547071106 @default.
• W3160658355 cites W2559946365 @default.
• W3160658355 cites W2560367415 @default.
• W3160658355 cites W2580794933 @default.
• W3160658355 cites W2590497374 @default.
• W3160658355 cites W2600281432 @default.
• W3160658355 cites W2606495925 @default.
• W3160658355 cites W2609349205 @default.
• W3160658355 cites W2754070259 @default.
• W3160658355 cites W2764040657 @default.
• W3160658355 cites W2767198352 @default.
• W3160658355 cites W2785630001 @default.
• W3160658355 cites W2791657935 @default.
• W3160658355 cites W2800568511 @default.
• W3160658355 cites W2886443268 @default.
• W3160658355 cites W2900082702 @default.
• W3160658355 cites W2909679049 @default.
• W3160658355 cites W2911871569 @default.
• W3160658355 cites W2913484031 @default.
• W3160658355 cites W2947310422 @default.
• W3160658355 cites W2980663762 @default.
• W3160658355 cites W3026551532 @default.
• W3160658355 cites W3083705725 @default.
• W3160658355 cites W3100136805 @default.
• W3160658355 doi "https://doi.org/10.1002/1878-0261.13015" @default.
• W3160658355 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34018316" @default.
• W3160658355 hasPublicationYear "2021" @default.
• W3160658355 type Work @default.
• W3160658355 sameAs 3160658355 @default.
• W3160658355 citedByCount "6" @default.
• W3160658355 countsByYear W31606583552022 @default.
• W3160658355 countsByYear W31606583552023 @default.
• W3160658355 crossrefType "journal-article" @default.
• W3160658355 hasAuthorship W3160658355A5000299131 @default.
• W3160658355 hasAuthorship W3160658355A5004172331 @default.
• W3160658355 hasAuthorship W3160658355A5004222553 @default.
• W3160658355 hasAuthorship W3160658355A5006614002 @default.
• W3160658355 hasAuthorship W3160658355A5017762827 @default.
• W3160658355 hasAuthorship W3160658355A5030356918 @default.
• W3160658355 hasAuthorship W3160658355A5044799176 @default.
• W3160658355 hasAuthorship W3160658355A5045491737 @default.
• W3160658355 hasAuthorship W3160658355A5064975863 @default.
• W3160658355 hasAuthorship W3160658355A5065750301 @default.
• W3160658355 hasAuthorship W3160658355A5077199450 @default.
• W3160658355 hasBestOaLocation W31606583551 @default.
• W3160658355 hasConcept C104317684 @default.
• W3160658355 hasConcept C126322002 @default.
• W3160658355 hasConcept C140173407 @default.
• W3160658355 hasConcept C143589142 @default.
• W3160658355 hasConcept C143998085 @default.
• W3160658355 hasConcept C150194340 @default.
• W3160658355 hasConcept C180754005 @default.
• W3160658355 hasConcept C181199279 @default.
• W3160658355 hasConcept C188816634 @default.
• W3160658355 hasConcept C190727270 @default.
• W3160658355 hasConcept C2776689207 @default.
• W3160658355 hasConcept C2777150147 @default.
• W3160658355 hasConcept C2777389519 @default.
• W3160658355 hasConcept C2779527866 @default.
• W3160658355 hasConcept C33288867 @default.
• W3160658355 hasConcept C501734568 @default.

• next